Toward a Framework to Assess the Financial and Economic Burden of Cervical Cancer in Low- and Middle-Income Countries: A Systematic Review The Brazilian Public Health System (BPHS) serves ...

Nubeqa (darolutamide) received FDA approval for metastatic castration-sensitive prostate cancer, showing significant improvement in radiographic progression-free survival. The ARANOTE trial involved ...

An expert explains the necessity of managing patients’ testosterone levels while treating prostate cancer. When treating patients with prostate cancer, controlling testosterone levels in the body is ...

Several novel therapies for castration-resistant prostate cancer (CRPC) have been approved with randomized phase III studies with continuing observational research either planned or ongoing.